Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0001415889-25-002264

Director acquired 1,111,111 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Rhodes Jason P Director 2025-01-27 Grant or award +1,111,111 $13.50 $14,999,999 1,958,427 I
Loading xslF345X05/form4-01292025_040102.xml…